We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+6.22%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$9.41B
AUM Growth
+$892M
Cap. Flow
+$716M
Cap. Flow %
7.61%
Top 10 Hldgs %
12.32%
Holding
577
New
120
Increased
118
Reduced
120
Closed
208

Sector Composition

Rank Sector Weight
1 Industrials 17.29%
2 Technology 14.74%
3 Healthcare 14.44%
4 Financials 13.07%
5 Energy 8.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRE icon
326
Sempra
SRE
$54.8B
$1.3M 0.01%
27,678
-493,090
-95% -$24.4M
JCAP
327
DELISTED
Jernigan Capital, Inc.
JCAP
$1.28M 0.01%
85,795
-171,492
-67% -$2.89M
GNRC icon
328
Generac Holdings
GNRC
$12.5B
$1.26M 0.01%
+42,179
New +$1.26M
SVRA icon
329
CALL
Savara
SVRA
$1.19B
$1.25M 0.01%
42,420
HAL icon
330
Halliburton
HAL
$26.6B
$1.22M 0.01%
35,914
-310,907
-90% -$11.7M
ACSF
331
DELISTED
American Capital Senior Floating, Ltd.
ACSF
$1.2M 0.01%
122,223
-88,344
-42% -$944K
BETR
332
DELISTED
Amplify Snack Brands, Inc.
BETR
$1.15M 0.01%
100,000
VNCE icon
333
Vince Holding Corp
VNCE
$86.8M
$1.13M 0.01%
24,700
-1,876
-7% -$84.4K
GWR
334
DELISTED
Genesee & Wyoming Inc.
GWR
$1.11M 0.01%
+20,595
New +$1.3M
TAL
335
DELISTED
TAL INTERNATIONAL GROUP, INC.
TAL
$1.11M 0.01%
+69,567
New +$1.22M
NGNE icon
336
Neurogene
NGNE
$712M
$1.1M 0.01%
4,400
+179
+4% +$47.1K
LRMR icon
337
Larimar Therapeutics
LRMR
$432M
$1.07M 0.01%
+14,176
New +$2.28M
CYTO
338
DELISTED
Altamira Therapeutics Ltd
CYTO
$1.02M 0.01%
3
-1
-25% -$288K
ATRS
339
DELISTED
Antares Pharma, Inc.
ATRS
$996K 0.01%
822,969
+33,553
+4% +$46.7K
SHOP icon
340
Shopify
SHOP
$195B
$973K 0.01%
+377,160
New +$1.11M
CTIC
341
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$923K 0.01%
+75,000
New +$1M
EXAS
342
DELISTED
Exact Sciences
EXAS
$901K 0.01%
97,569
+32,861
+51% +$306K
VTVT icon
343
vTv Therapeutics
VTVT
$139M
$901K 0.01%
3,309
+135
+4% +$37.9K
TBCH
344
Turtle Beach Corp
TBCH
$277M
$881K 0.01%
109,563
+4,467
+4% +$42.5K
GNCA
345
DELISTED
Genocea Biosciences, Inc.
GNCA
$864K 0.01%
20,482
-2,289
-10% -$109K
ASRT
346
DELISTED
Assertio
ASRT
$854K 0.01%
+785
New +$883K
DARE icon
347
Dare Bioscience
DARE
$21M
$849K 0.01%
2,526
+155
+7% +$64.3K
BIOA
348
CALL
DELISTED
BioAmber Inc.
BIOA
$769K 0.01%
124,383
+10,557
+9% +$79.5K
PARN
349
DELISTED
Parnell Pharmaceuticals Holdings Ltd
PARN
$739K 0.01%
190,501
-31,393
-14% -$119K
HES
350
DELISTED
Hess
HES
$723K 0.01%
+14,915
New +$847K

Similar funds

Alyeska Investment Group's Q4 2015 Portfolio in Review

As of Q4 2015, Alyeska Investment Group held 577 positions worth $9.41B, up 10% from $8.52B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Alyeska Investment Group deployed $716M of net new capital in Q4 2015, opening 120 new positions and adding to 118 existing holdings. Its largest new stake was Hewlett Packard: 15,626,018 shares worth $138M.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Bankunited, an estimated $43.3M trimmed.

  • Alyeska Investment Group's largest Q4 2015 buy was Hewlett Packard: 15,626,018 shares worth $138M.
  • Alyeska Investment Group added most to Synchrony in Q4 2015, an estimated $120M increase.
  • Alyeska Investment Group's biggest Q4 2015 reduction was Bankunited, cutting an estimated $43.3M.
  • Alyeska Investment Group fully exited GE Aerospace in Q4 2015, selling an estimated $112M.
  • Alyeska Investment Group's ten largest holdings make up 12% of its $9.41B portfolio in Q4 2015.
  • Alyeska Investment Group opened 120 new positions and closed 208 in Q4 2015.
  • Alyeska Investment Group's portfolio value rose 10% quarter-over-quarter to $9.41B.

Based on Alyeska Investment Group's 13F filing for Q4 2015, filed 16 Feb 2016.